$ Value
$1.2M
Shares
10,954
Price
$111
Filed
Feb 12
Insider
Name
Tarr Mark J
Title
President & CEO
CIK
0001304057
Roles
Transaction Details
Transaction Date
2026-02-11
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
471,085
Footnotes
This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.47 to $108.45, inclusive. The reporting pers on undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.47 to $109.17, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.52 to $110.51, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.52 to $111.51, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.55 to $112.53, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.58 to $113.52, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
Filing Info
Tarr Mark J's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | EHC | A | $3.8M |
| 2026-02-28 | EHC | F | $236K |
| 2026-02-23 | EHC | F | $264K |
| 2026-02-20 | EHC | F | $191K |
| 2026-02-19 | EHC | A | $0 |
| 2026-02-19 | EHC | F | $4.6M |
| 2026-02-18 | EHC | A | $0 |
| 2026-02-11 | EHC | ▼ | $1.8M |
| 2026-02-11 | EHC | ▼ | $1.4M |
| 2026-02-11 | EHC | ▼ | $1.7M |
Other Insiders at EHC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
|
— | — | 2026-03-02 |
| KATZ LESLYE G | — | — | 2026-04-15 |
| CARMICHAEL GREG D | — | — | 2026-04-15 |
| HERMAN JOAN E | — | — | 2026-04-15 |
| Reidy Christopher R | — | — | 2026-04-16 |
|
Tarr Mark J
President & CEO
|
— | $15.5M | 2026-03-02 |
| SCHLICHTING NANCY M | — | — | 2026-04-15 |
| Christie Edward M III | — | — | 2026-04-16 |
|
Fay Edmund
Sr. Vice Pres. and Treasurer
|
— | — | 2026-02-28 |
|
Price Andrew L
Chief Accounting Officer
|
— | — | 2026-02-28 |
|
Charbonneau Elissa Joy
Chief Medical Officer
|
— | — | 2026-02-28 |
|
Darby John Patrick
EVP, Gen Counsel & Secretary
|
— | — | 2026-03-02 |
| Williams Terrance | — | — | 2026-04-15 |
| O'Connor Kevin J. | — | — | 2026-04-15 |
| Hayes Cain A | — | — | 2026-04-15 |
|
Tuer Patrick William
EVP, Chief Operating Officer
|
— | $302K | 2026-03-02 |